BioSurplus Revenue and Competitors

Location

$3.9M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • BioSurplus's estimated annual revenue is currently $1.3M per year.(i)
  • BioSurplus's estimated revenue per employee is $77,500
  • BioSurplus's total funding is $3.9M.

Employee Data

  • BioSurplus has 17 Employees.(i)
  • BioSurplus grew their employee count by 0% last year.

BioSurplus's People

NameTitleEmail/Phone
1
Inventory Control SpecialistReveal Email/Phone
2
Senior Warehouse Associate & Inventory Control SpecialistReveal Email/Phone
3
Business Development Account Manager - Southwestern USReveal Email/Phone
4
Customer Service SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is BioSurplus?

Founded in 2002, BioSurplus is America's preeminent buyer and reseller of preowned lab equipment. Customers can shop from anywhere using the BioSurplus online store, online auctions or visit us in California in one of our two showrooms. BioSurplus purchases late model working lab instruments from labs that no longer need them, and then passes on the savings of repurposed equipment to its customers. The BioSurplus team is carefully chosen for their scientific experience and background to ensure the proper marketing, selling and handling of a wide range of laboratory instruments. BioSurplus is dedicated to maximizing the value and use of laboratory equipment for both its buying and selling customers.

keywords:N/A

$3.9M

Total Funding

17

Number of Employees

$1.3M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

BioSurplus News

2022-03-30 - ARS Pharmaceuticals Appoints Eric Karas as Chief Commercial Officer and Kathleen Scott as Chief Financial Officer

... including Neurana Pharmaceuticals, Recros Medica, Adigica Health, Clarify Medical, Oncternal Therapeutics, MDRejuvena and BioSurplus.

2012-05-10 - BioSurplus Gets $1.5M For Boston Expansion

San Diego-based BioSurplus, a provider of pre-owned, laboratory instruments for the life sciences industry, said today that it has raised $1.5M in a capital raise for an expansion into Boston. The firm said the funding came from KI Investment Holdings. BioSurplus offers up used and surplus labor ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.8M176%$21.4M
#2
$3.6M17N/AN/A
#3
$1.5M17N/AN/A
#4
$1.5M17N/AN/A
#5
$1.5M17N/AN/A